{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1270, 
        1274
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1275, 
        1284
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1428, 
        1451
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1531, 
        1551
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1174, 
        1201
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1152, 
        1156
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1214, 
        1218
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        537, 
        566
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1117, 
        1143
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1145, 
        1151
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1157, 
        1163
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1219, 
        1225
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 2^9999^MOH|PIMS|CCO-OCR|20160503094200|0042DFD04504A8D0141205796D4D206EFD293C51|ORU^R01|9999999999999999|P|2.5|\nPID|1||SA99999999^^^^CMR^HOSPITAL 2&9999&MOH~SA99999999^^^^MRN^HOSPITAL 2&9999&MOH~9999999999&MY&ON^^^^JHN||XXXXXXX^XXXX^X||99999999|F||||||||||||||||||||||N|\nOBR|1||S16-25644|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604210910|||31832^XXXXXX^XXXXXXX||||201604211423|&Breast:Left breast core bx|99999^XXXXXX^XXXXXXX||||||201604251507||S|C|||||||99999^XXXXXXX^XXXXXXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\nThe specimen labeled with the patient's name and as \"left breast biopsy\", consists of 3 core like pieces of tan tissue measuring from 1.3 to 2.0 cm in length x 0.2 cm in diameter, received in 10% buffered formalin.\n1A submitted in toto\n\nSpecimen received with documentation as follows:\n\nTime tissue excised: 0910 hrs. April 21, 2016\nTime tissue received in lab: 1300 hrs. April 21, 2016\nTime tissue placed in formalin: 0915 hrs. April 21, 2016\nDate tissue sent for processing: 0850 hrs. April 22, 2016\nTotal fixation time: Approximately 82 hours\n\n\n\nPath report.site of origin\n\nBreast:Left breast core bx\n\n\nPath report.final diagnosis\n\n1 breast.: Left breast core biopsy (1) 3 cores of and infiltrating duct carcinoma of no special type.(2) no evidence of lymphatic vascular or perineural infiltration is identified.(3) slides have been sent for biomarkers.\n\n\n\nPath report.relevant Hx\n\n\n\nLeft breast 5:00 spiculated mass 2x1.2x1.3, (3x14 g core)\nER PR HER2NEW.\n\n\n\nPath report.comments\n\n1. Sections show all 3 cores of the breast biopsy tissue to consist of an infiltrating duct carcinoma of no special type. There is no evidence within lymphatic, vascular perineural infiltration in the sections examined. Slides have been sent for biomarkers.\n\nBIOMARKER STUDIES\n\nBlock / Tumor Stained:   Block: 1A\n   -Invasive breast carcinoma\nTEST(S) PERFORMED\nEstrogen Receptor (ER) Status:\n--POSITIVE\n---Tumor cells with Nuclear Positivity:   ----51-60%\n---Average Intensity of Staining:   ----Moderate\n-Test Type:   --Laboratory-developed test\n-Primary Antibody:   --SP1\nProgesterone Receptor (PgR) Status:\n--POSITIVE\n---Tumor cells with Nuclear Positivity:   ----11-20%\n---Average Intensity of Staining:   ----Moderate\n-Test Type:   --Laboratory-developed test\n-Primary Antibody:   --16\nHER2 by Immunohistochemistry (IHC):\n--NEGATIVE (Score 0)\n-Uniform Intense Complete Membrane Staining (%): 0\n-Test Type:   --Laboratory-developed test\n-Primary Antibody:   --4B5\nMETHODS\nCold Ischemia and Fixation Times:   Do not meet requirements specified in latest version of the ASCO / CAP Guidelines\nFixative:   Formalin\n   COMMENT\nTime from excision to immersion in formalin 5 minutes, time in formalin 82 hours\n\n\n\n\n\n"
}